HomeStock ScreenerTranschem

Transchem Share Price | Transchem Stock Screener

TRANSCHEM Pharmaceuticals
Share Price BSE
₹167.30
▼ -8.75 (-4.97%)
2026-05-20 00:00:00
As of May 20, 2026, the Transchem share price (BSE: TRANSCHEM) is ₹167.30, down 4.97% from the previous close, with shares trading between ₹167.25 and ₹179.05, and a 52-week range of ₹37.90–₹204.90. Check Transchem yearly highs lows for the annual price range and momentum. Use the Transchem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Transchem Market Cap ₹226.77 Cr.
TRANSCHEM P/E Ratio (TTM) 55.57
Transchem P/B Ratio 2.86
EPS (TTM) ₹3.51
Dividend Yield -
Debt to Equity -
TRANSCHEM 52 Week High ₹204.90
Transchem 52 Week Low ₹37.90
Operating Margin -
Profit Margin -
TRANSCHEM Revenue (TTM) -
EBITDA ₹-4.00
Net Income ₹4.00
Total Assets ₹80.00
Total Equity ₹79.00

Transchem Share Price Chart

Screen Transchem share price with an interactive chart. Analyse TRANSCHEM price trends and volatility across different timeframes.

Transchem Company Profile - Fundamental Screener

Screen Transchem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TRANSCHEM shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE019B01010

Transchem Balance Sheet Screener

Screen TRANSCHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Assets
Total Assets 80 76 66 67 63 37 38 37 38 39
Current Assets 78 67 58 58 55 30 28 30 29 28
Fixed Assets 0 0 0 0 0 4 4 5 6 7
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 79 76 66 66 63 37 38 37 38 38
Share Capital 12 12 12 12 12 12 12 12 12 12
Reserves & Surplus 67 63 54 54 51 25 26 25 26 26

Transchem Income Statement Screener - Profit & Revenue Analysis

Screen Transchem income statement and profit fundamentals. Analyze TRANSCHEM quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Transchem share price evaluation.
Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March
Revenue 0 11 8 4 7 27 3 3 2 2 2 2
Expenses 4 4 2 2 3 2 1 1 2 1 1 1
EBITDA -4 7 6 3 4 25 1 2 0 1 1 1
Operating Profit % 0.00% -56.00% -423.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 1 1 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 6 7 6 3 4 25 1 1 -1 0 0 0
Tax 2 2 1 1 1 1 0 1 1 0 0 0
Net Profit 4 5 4 1 3 24 0 0 -1 0 0 0
EPS 3.51 4.27 3.43 1.01 2.34 19.73 0.33 0.25 -0.97 -0.18 0.04 0.10

Transchem Cash Flow Screener - Liquidity Fundamentals

Screen TRANSCHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities 36 -39 1 22 -28 -1 10 -20 1 1
Investing Activities 6 5 -1 1 23 1 6 20 -2 0
Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 42 -34 0 23 -5 0 16 0 -1 1

Transchem Shareholding Pattern Screener

See Transchem shareholding pattern with promoter, FII, and DII holdings. Check Transchem promoter holding and ownership changes for TRANSCHEM on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 56.45% 56.45% 56.45% 56.45% 56.45% 51.68% 51.68% 51.68%
FII Holding 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%
DII Holding 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 20.83% 24.69% 24.75% 23.38% 21.78% 27.15% 27.22% 27.37%
Other Holding 22.68% 18.83% 18.76% 20.14% 21.73% 21.14% 21.07% 20.92%
Shareholder Count 13,145 13,843 13,767 13,680 13,339 13,813 13,681 13,647

Transchem Share Dividend Screener - Share Yield Analysis

Check Transchem dividend history with payout and yield data. View Transchem dividend details including ex-dates and amounts for TRANSCHEM stock.
No dividends declared by Transchem.

Transchem Stock Index Membership

See which indices include Transchem stock. Check TRANSCHEM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Transchem is not part of any tracked indices.
Only major market indices are tracked in our system.

Transchem Market Events Screener - Corporate Actions

Get Transchem corporate actions including splits, bonuses, and buybacks. Check Transchem stock events that may affect TRANSCHEM share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-05 2026-05-05 Quarterly Result Announcement NA 1.20%
2026-02-07 2026-02-07 Quarterly Result Announcement NA -3.29%
2025-12-20 2025-12-20 Extraordinary General Meeting NA 126.06%
2025-10-16 2025-10-16 Extraordinary General Meeting NA -17.83%
2025-10-16 2025-10-16 Quarterly Result Announcement NA -1.48%
2025-08-23 2025-08-23 Annual General Meeting NA 15.27%
2025-08-07 2025-08-07 Quarterly Result Announcement NA 2.20%
2025-05-20 2025-05-20 Quarterly Result Announcement NA -1.96%
2025-01-28 2025-01-28 Quarterly Result Announcement NA -7.99%
2024-10-15 2024-10-15 Quarterly Result Announcement NA 9.22%
2024-08-24 2024-08-24 Annual General Meeting NA -5.31%

Transchem Competitors Screener - Peer Comparison

Screen TRANSCHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 457,265 41.18 54,729 9.71% 10,980 67.81
Divis Laboratories 181,448 72.40 9,712 18.67% 2,191 66.76
Torrent Pharmaceuticals 148,703 65.64 11,539 6.99% 1,911 57.60
Cipla 115,206 29.94 27,712 -2.46% 3,783 68.41
Dr Reddys Laboratories 111,108 26.84 33,593 -0.44% 3,998 58.65
Mankind Pharma 103,024 57.32 12,744 20.90% 2,007 72.21
Lupin 102,944 19.41 27,488 19.98% 5,345 43.67
Zydus Life Science 99,728 20.25 23,511 18.55% 4,615 63.02
Aurobindo Pharma 87,149 25.19 32,346 9.43% 3,484 69.63
Laurus Labs 71,655 80.32 6,813 21.03% 884 80.55

Transchem Company Announcements - News Screener

Screen TRANSCHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-05-14 Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 -
2026-05-07 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-05 Announcement under Regulation 30 (LODR)-Change in Management -
2026-05-05 Audited Financial Results For The Quarter And Year Ended March 31 2026 -
2026-05-05 Board Meeting Outcome for The Meeting Held On May 05 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-04-28 Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026. -
2026-04-15 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-24 Closure of Trading Window -
2026-02-09 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-07 Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 Along With Limited Review Report. -
2026-02-07 Board Meeting Outcome for The Meeting Held On February 07 2026 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. -
2026-02-02 Board Meeting Intimation for For Approval Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. -
2026-01-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-26 Closure of Trading Window -
2025-12-22 Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association -
2025-12-22 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2025-12-20 Shareholder Meeting / Postal Ballot-Outcome of EGM -
2025-12-16 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-12-15 Corrigendum To The Notice Of The 2Nd Extra-Ordinary General Meeting Of The Members Of Transchem Limited For The Financial Year 2025-26 Scheduled To Be Held On Saturday December 20 2025. -